CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $1.51B, above the global median of $1.18B
- PositionOperating margin is 57.8%, higher than 95% of its Medical Care Facilities peers (median 11.3%)
- Interpretations9 currently firing — 9
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.51BUSDvs all stocks (USD)
Trailing P/E
8.53xvs Medical Care Facilities peers
Revenue (TTM)
846.72MUSDvs all stocks (USD)
Profit Margin
21.25%vs Medical Care Facilities peers
Beta
2.02xvs all stocks
52-Week Change
107.20%vs all stocks
Market Capitalization
1.51BUSDvs all stocks (USD)
Enterprise Value
1.76BUSDvs all stocks (USD)
Trailing P/E
8.53xvs Medical Care Facilities peers
Forward P/E
10.83xvs Medical Care Facilities peers
PEG Ratio
-0.0201xvs Medical Care Facilities peers
Price to Sales (TTM)
1.78xvs Medical Care Facilities peers
Price to Book (MRQ)
3.82xvs Medical Care Facilities peers
Enterprise to Revenue
2.08xvs Medical Care Facilities peers
Enterprise to EBITDA
3.51xvs Medical Care Facilities peers
Gross Margin
67.04%vs Medical Care Facilities peers
Profit Margin
21.25%vs Medical Care Facilities peers
Operating Margin
57.75%vs Medical Care Facilities peers
Return on Assets (TTM)
33.32%vs Medical Care Facilities peers
Return on Equity (TTM)
64.56%vs Medical Care Facilities peers
Revenue (TTM)
846.72MUSDvs all stocks (USD)
Revenue per Share (TTM)
123.99USDUpdated Sep 28, 2026Quarterly Revenue Growth
-13.60%vs Medical Care Facilities peers
Gross Profit (TTM)
461.53MUSDvs all stocks (USD)
EBITDA (TTM)
384.26MUSDvs all stocks (USD)
Net Income (TTM)
179.92MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-13.62%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
279.62MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
130.75MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
93.99MUSDFY2025 · Dec 31, 2025Revenue
875.26MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
430.98MUSDFY2025 · Dec 31, 2025Gross Profit
444.28MUSDFY2025 · Dec 31, 2025Operating Income
275.63MUSDvs all stocks (USD)
Pre-tax Income
244.78MUSDFY2025 · Dec 31, 2025Income Tax Expense
64.42MUSDFY2025 · Dec 31, 2025Net Income
180.36MUSDFY2025 · Dec 31, 2025EBIT
267.01MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
287.54MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
168.66MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
22.23MUSDFY2025 · Dec 31, 2025EPS (Basic)
11.13USDFY2025 · Dec 31, 2025EPS (Diluted)
10.48USDFY2025 · Dec 31, 2025Basic Shares Outstanding
6.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
6.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
180.36MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-109.57MUSDFY2025 · Dec 31, 2025Operating Cash Flow
284.80MUSDFY2025 · Dec 31, 2025Free Cash Flow
282.27MUSDDerived from operating cash flow minus capital expenditure. This filing charges 20.53M of depreciation against 2.53M of capital expenditure, and its own free-cash-flow line reads 245.6M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
185.87MUSDFY2025 · Dec 31, 2025Income Tax Paid
72.81MUSDFY2025 · Dec 31, 2025Interest Paid
2.51MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
180.36MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
20.53MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
17.08MUSDFY2025 · Dec 31, 2025Stock-based Compensation
117.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
902.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-89.32MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
37.85MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
393.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-2.53MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Sale of Investments
1.60MUSDFY2025 · Dec 31, 2025Other Investing Activity
-4.31MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-5.24MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
5.04MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-24.48MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-5.00MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-74.28MUSDFY2025 · Dec 31, 2025Other Financing Charges
767.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-97.95MUSDFY2025 · Dec 31, 2025Shares Outstanding
6.84MSharesUpdated Sep 28, 2026Float Shares
4.15MSharesUpdated Sep 28, 2026Shares Short
1.23MSharesUpdated Sep 28, 2026Short Ratio
8.23daysvs all stocks
Short % of Shares Outstanding
28.56%vs all stocks
% Held by Insiders
29.23%vs all stocks
% Held by Institutions
43.93%vs all stocks
Total Cash (MRQ)
205.21MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
29.97USDUpdated Sep 28, 2026Total Debt (MRQ)
347.34MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6847xvs Medical Care Facilities peers
Current Ratio (MRQ)
5.00xvs Medical Care Facilities peers
Book Value per Share (MRQ)
57.62USDUpdated Sep 28, 2026Total Assets
918.52MUSDvs all stocks (USD)
Total Current Assets
538.81MUSDFY2025 · Dec 31, 2025Total Liabilities
495.09MUSDFY2025 · Dec 31, 2025Total Non-current Assets
379.71MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
337.18MUSDFY2025 · Dec 31, 2025Total Current Liabilities
157.91MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
185.57MUSDFY2025 · Dec 31, 2025Accounts Receivable
325.42MUSDFY2025 · Dec 31, 2025Inventory
2.87MUSDFY2025 · Dec 31, 2025Accounts Payable
48.97MUSDFY2025 · Dec 31, 2025Short-term Debt
23.30MUSDFY2025 · Dec 31, 2025Long-term Debt
328.09MUSDFY2025 · Dec 31, 2025Common Stock (Book)
7.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-286.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
423.44MUSDvs all stocks (USD)
52-Week Low
83.99USDUpdated Sep 28, 202652-Week High
224.28USDUpdated Sep 28, 202652-Week Change
107.20%vs all stocks
Beta
2.02xvs all stocks
50-Day MA
181.38USDUpdated Sep 28, 2026200-Day MA
146.12USDUpdated Sep 28, 2026Avg 10-Day Volume
160.25KSharesUpdated Sep 28, 2026Avg 30-Day Volume
150.94KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
25.80USDUpdated Sep 28, 2026Other Income / Expense
-8.62MUSDFY2025 · Dec 31, 20259 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Elevated Receivables Alongside Balance-Sheet Strength
Liquidity looks comfortable, but it rests on customer debts that have grown three years.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
SBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)
Pay in shares is large next to its revenue and its profit, and the share count keeps rising.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 57.8%, higher than 95% of its Medical Care Facilities peers (median 11.3%)Significant
Operating margin: 0.58Industry median: 0.11Industry P95: 0.26Peers compared: 69.00
Return on equity is 64.6%, higher than 95% of its Medical Care Facilities peers (median 12.1%)Significant
Return on equity: 0.65Industry median: 0.12Industry P95: 0.42Peers compared: 69.00
Return on assets is 33.3%, higher than 95% of its Medical Care Facilities peers (median 5.8%)Significant
Return on assets: 0.33Industry median: 0.06Industry P95: 0.17Peers compared: 69.00
Current ratio is 5×, higher than 95% of its Medical Care Facilities peers (median 1.6×)Significant
Current ratio: 5.00Industry median: 1.60Industry P95: 4.36Peers compared: 69.00
Financial Health
Altman Z-Score 3.8: safe zoneNotable
Altman Z-Score: 3.80
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.51B, above the global median of $1.18BNotable
Market cap (USD): 1,507,307,337Global Median: 1,180,223,658.953
Revenue is $846.72M, above the global median of $548.88MNotable
Revenue (USD): 846,720,000Global Median: 548,883,780.48
Levered free cash flow is $130.75M, above the global median of $18.73MNotable
Levered free cash flow (USD): 130,745,376Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Yunyi Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Energizer Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CAC Nantong Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Tong Hsing Electronic Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wankai New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Anhui Shenjian New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Precision Tsugami (China) Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Wanma Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai YCT Electronics Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
India Cements Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Aryt Industries Ltd.
6 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthLiquidity Ratios Elevated
Vulcabras S.A.
6 interpretationsFCF Ratios ElevatedReceivables Heavy and GrowingROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue Growth
Halozyme Therapeutics Inc.
6 interpretationsFCF Ratios ElevatedReceivables Heavy and GrowingROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue Growth